Green dye vs standard surgery for pancreas tail tumors
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial compares standard laparoscopic surgery to surgery using a green dye that helps the surgeon see the pancreas more clearly. It may help patients needing removal of tumors in the body or tail of the pancreas.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your body mass index (BMI) is 40 or less.
- You have a tumor in the body or tail of the pancreas that can be removed with laparoscopic (minimally invasive) surgery.
- You are in generally good health (able to do daily activities without significant limitation).
- Your liver and blood clotting function are within safe limits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a green dye called indocyanine green (ICG) that is injected during pancreas surgery to see how well blood flows to the remaining tissue. The goal is to learn if this dye can help predict complications, such as leaks from the pancreas, after surgery.
This trial tests whether a green dye called indocyanine green can help surgeons find and remove more lymph nodes during laparoscopic surgery for advanced stomach cancer. It may improve the chances of removing all cancer.
This trial tests if a green dye helps surgeons see and remove lymph nodes more clearly during 3D laparoscopic stomach cancer surgery. The goal is to confirm the dye's safety and benefit for patients undergoing this procedure.
This trial tests whether a special dye (SGM-101) can help surgeons see remaining cancer cells during surgery for pancreatic cancer that has been treated before surgery. It may lead to more complete removal of the tumor.
This trial tests whether a special green dye (indocyanine green) injected during minimally invasive stomach cancer surgery helps doctors remove more lymph nodes, which may improve treatment. It is for people with stomach adenocarcinoma that has not spread to distant organs.
This Phase 2 study tests whether using a special light-activated dye (indocyanine green) during laparoscopic stomach surgery can improve surgical outcomes for people with remnant (leftover) stomach cancer that has not spread to distant organs. It may help surgeons better find lymph nodes while operating.
Hear when a new Pancreatic Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.